DAVIS, Calif., March 2, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that it will be presenting at the H.C. Wainwright Global Life Sciences Conference. The conference will be held virtually March 9-10, 2021.
Matt Plavan, Arcadia's president and CEO will present an overview of the company's business and will be available for one-on-one web meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hcwevents.com/globalconference.
The presentation will be available on-demand here starting on March 9 at 7:00 AM (EST). A replay will be available in the Investors section of the company's website.
About Arcadia Biosciences Arcadia Biosciences (Nasdaq: RKDA) is a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients. The company's GoodHemp™ seed catalog delivers genetically superior hemp seeds, transplants and extracts, applying the company's proprietary crop innovation technology, ArcaTech™, to an emerging crop. The company's GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. For more information, visit www.arcadiabio.com.